Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

87
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
87
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

49
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
49
Jaundice01:25

Jaundice

44
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
44

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association Between Ventricular-Arterial Coupling and C-Reactive Protein in Patients at Risk for Heart Failure.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Targeting MLL1/WDR5-Mediated Epigenetic Regulation Mitigates Peritoneal Fibrosis by Reducing p16<sup>INK4a</sup>.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

Effects of low-intensity pulsed ultrasound on clinical parameters in atherosclerotic peripheral artery disease patients with chronic limb-threatening ischemia.

Scientific reports·2025
Same author

Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial.

Cardiovascular diabetology·2025
Same author

A Severe Case of Rhabdomyolysis Requiring Renal Replacement Therapy Following COVID-19 mRNA Vaccination.

Internal medicine (Tokyo, Japan)·2025
Same author

Responses of the carotid artery to acute, fractionated or chronic ionizing irradiation, and differences from the aorta.

Scientific reports·2025

相关实验视频

Updated: May 6, 2026

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
12:35

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

Published on: November 10, 2011

20.3K

在吉尔伯特综合征中,高白血症,内皮功能增强,氧化应激减小.

Tatsuya Maruhashi1, Junko Soga, Noritaka Fujimura

  • 1Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.

Circulation
|July 10, 2012
PubMed
概括

吉尔伯特综合征患者由于胆红素水平较高,氧化应激减少,内皮功能改善. 这表明比利鲁宾.

更多相关视频

Quantification of Reactive Oxygen Species Using 2&#8242;,7&#8242;-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in M&#252;ller Glial Cells
14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

6.2K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

相关实验视频

Last Updated: May 6, 2026

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
12:35

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion

Published on: November 10, 2011

20.3K
Quantification of Reactive Oxygen Species Using 2&#8242;,7&#8242;-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in M&#252;ller Glial Cells
14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

6.2K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

科学领域:

  • 心血管科学 心血管科学
  • 内分泌学 在内分泌学.
  • 代谢障碍 代谢障碍 代谢障碍

背景情况:

  • 吉尔伯特综合征的特征是轻微的非结合性高 bilirubinemia.
  • 比利鲁被认为是一种内源性抗氧化剂.
  • 这项研究研究了吉尔伯特综合征患者没有心血管风险因素的氧化应激.

研究的目的:

  • 评估氧化应激在吉尔伯特综合征患者内皮功能中的作用.
  • 评估超白血病对血管健康的影响.
  • 确定胆红素水平,氧化应激标志物和内皮功能之间的关系.

主要方法:

  • 一项涉及108名患有吉尔伯特综合征的年轻男性和108名年龄相匹配的健康对照的研究.
  • 测量血清胆红素,低密度脂蛋白 (MDA-LDL) 和尿中的8-基-2'-脱氧氨酸 (8-OHdG) 作为氧化应激标志物.
  • 评估流介导血管扩张 (FMD) 以评估内皮功能.

主要成果:

  • 吉尔伯特综合征患者血清胆红素水平显著上升 (P<0.001).
  • 在吉尔伯特综合征患者中观察到较低水平的氧化应激标志物 (MDA-LDL和8-OHdG) (分别P=0.034和P=0.001).
  • 与对照组相比,在吉尔伯特综合征患者中发现了增强的流量介导血管扩张 (P<0.001).

结论:

  • 吉尔伯特综合征与氧化应激降低和胆红素水平升高有关.
  • 在吉尔伯特综合征中,高 bilirubinemia 与内皮依赖血管扩张的改善相关.
  • 这些发现强调了胆红素在血管健康中的潜在保护作用.